Pharmacist's Verdict
Dulcolax (bisacodyl) is a strong and effective stimulant laxative best used for quick, short-term relief of occasional constipation. It should not be used daily or for long periods due to potential side effects and dependence.
Ingredient Analysis
Bisacodyl
Pros & Cons
Pros
- Highly effective for relieving occasional constipation.
- Works relatively quickly, often within 6-12 hours for oral tablets and 15-60 minutes for suppositories.
- Readily available over-the-counter without a prescription.
- Can be used for bowel preparation before certain medical procedures under doctor's guidance.
Cons
- Can cause significant abdominal cramps, pain, and discomfort.
- Not intended for long-term or daily use, as it can lead to 'laxative dependence' where your bowels may struggle to move on their own.
- Potential side effects include faintness, rectal burning (especially with suppositories), and electrolyte imbalances with overuse.
- Should not be taken within one hour of consuming milk or antacids, as these can cause the tablet to dissolve too quickly and lead to stomach upset.
Safety Information
Warnings
Warnings For rectal use only Ask a doctor before use if you have stomach pain, nausea or vomiting noticed a sudden change in bowel habits that lasts more than 2 weeks When using this product it may cause stomach discomfort, faintness, rectal burning and mild cramps Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after using this product. These could be signs of a serious condition. you need to use a laxative for more than 1 week If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Is Dulcolax safe for you?
See pregnancy, interactions, and common concerns answered in our pharmacist safety FAQ.
Read safety review →References
- 1.FDA Drug Label — Walgreens Gentle Laxative
FDA DailyMed: Walgreens Gentle Laxative · FDA
- 2.FDA Drug Label — Dulcolax Laxative
FDA DailyMed: Dulcolax Laxative · FDA
- 3.Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
Kistemaker KRJ, Sijani F, Brinkman DJ, et al., Cancer treatment reviews, 2024 · PubMed
- 4.American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation.
Chang L, Chey WD, Imdad A, et al., Gastroenterology, 2023 · PubMed
- 5.Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
Luthra P, Camilleri M, Burr NE, et al., The lancet. Gastroenterology & hepatology, 2019 · PubMed
- 6.Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review.
Rao SSC, Brenner DM, The American journal of gastroenterology, 2021 · PubMed